{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:24:10Z","timestamp":1790076250078,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-PH-107-02"],"award-info":[{"award-number":["TSGH-PH-107-02"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-C103-187"],"award-info":[{"award-number":["TSGH-C103-187"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-C104-195"],"award-info":[{"award-number":["TSGH-C104-195"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012910","name":"National Defense Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012910","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofhospitalinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jhin.2019.09.001","type":"journal-article","created":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T01:45:21Z","timestamp":1567820721000},"page":"46-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients"],"prefix":"10.1016","volume":"104","author":[{"given":"C.H.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-M.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-T.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.-X.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2019.09.001_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/CMR.00019-11","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jhin.2019.09.001_bib2","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1086\/522998","article-title":"Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer","volume":"45","author":"Safdar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.001_bib3","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2217\/fmb.09.84","article-title":"Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature","volume":"4","author":"Falagas","year":"2009","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jhin.2019.09.001_bib4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3389\/fmicb.2015.00893","article-title":"Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options","volume":"6","author":"Chang","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jhin.2019.09.001_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/eri.11.24","article-title":"Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment","volume":"9","author":"Abbott","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jhin.2019.09.001_bib6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1055\/s-2007-996414","article-title":"Optimizing therapy for Stenotrophomonas maltophilia","volume":"28","author":"Muder","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jhin.2019.09.001_bib7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/AAC.01324-13","article-title":"Monotherapy with fluoroquinolone or trimethoprim\u2013sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections","volume":"58","author":"Wang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2019.09.001_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/AAC.01682-13","article-title":"Can levofloxacin be a useful alternative to trimethoprim\u2013sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?","volume":"58","author":"Cho","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2019.09.001_bib9","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1128\/AAC.01774-09","article-title":"Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S.\u00a0maltophilia infections","volume":"54","author":"Farrell","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2019.09.001_bib10","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1093\/jac\/dky279","article-title":"Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015\u201317)","volume":"73","author":"Sader","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.jhin.2019.09.001_bib11","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1093\/ofid\/ofy293","article-title":"Antimicrobial susceptibility of Acinetobacter calcoaceticus\u2013Acinetobacter baumannii complex and Stenotrophomonas maltophilia clinical isolates: results from the SENTRY Antimicrobial Surveillance Program (1997\u20132016)","volume":"6","author":"Gales","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.001_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/mdr.2009.0134","article-title":"Case\u2013control studies reporting on risk factors for emergence of antimicrobial resistance: bias associated with the selection of the control group","volume":"16","author":"Rafailidis","year":"2010","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jhin.2019.09.001_bib13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1086\/319600","article-title":"Methodological principles of case\u2013control studies that analyzed risk factors for antibiotic resistance: a systematic review","volume":"32","author":"Harris","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.001_bib14","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3201\/eid1006.020665","article-title":"Reference group choice and antibiotic resistance outcomes","volume":"10","author":"Kaye","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.001_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.jhin.2019.09.001_bib16","series-title":"M100S 27","year":"2017"},{"key":"10.1016\/j.jhin.2019.09.001_bib17","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 7.1. V\u00e4xj\u00f6: EUCAST. 2017. Available at: http:\/\/www.eucast.org\/ast_of_bacteria\/previous_versions_of_ documents\/[last accessed August 2019]."},{"key":"10.1016\/j.jhin.2019.09.001_bib18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.diagmicrobio.2016.02.020","article-title":"Emergence of fluoroquinolone-resistant Stenotrophomonas maltophilia in blood isolates causing bacteremia: molecular epidemiology and microbiologic characteristics","volume":"85","author":"Cha","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.001_bib19","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/jac\/dkh094","article-title":"Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia","volume":"53","author":"Chang","year":"2004","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2019.09.001_bib20","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/AAC.00026-08","article-title":"Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia","volume":"52","author":"Shimizu","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2019.09.001_bib21","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1128\/AAC.40.12.2859","article-title":"Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in\u00a0vitro pharmacodynamic chamber model","volume":"40","author":"Garrison","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2019.09.001_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jac\/20.2.283-a","article-title":"Emergence of ofloxacin-resistant Citrobacter freundii and Pseudomonas maltophilia after ofloxacin therapy","volume":"20","author":"Cheng","year":"1987","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2019.09.001_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jmii.2013.09.005","article-title":"Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital","volume":"48","author":"Pien","year":"2015","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.jhin.2019.09.001_bib24","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3349\/ymj.2014.55.4.987","article-title":"Clinical factors associated with acquisition of resistance to levofloxacin in Stenotrophomonas maltophilia","volume":"55","author":"Baek","year":"2014","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jhin.2019.09.001_bib25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/502550","article-title":"The case\u2013case\u2013control study design: addressing the limitations of risk factor studies for antimicrobial resistance","volume":"26","author":"Kaye","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jhin.2019.09.001_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jamda.2010.06.012","article-title":"Assessment of risk factors for multi-drug resistant organisms to guide empiric antibiotic selection in long term care: a dilemma","volume":"12","author":"Drinka","year":"2011","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jhin.2019.09.001_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/1471-2334-12-375","article-title":"Additional risk factors for infection by multidrug-resistant pathogens in healthcare-associated infection: a large cohort study","volume":"12","author":"Cardoso","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.001_bib28","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.ijantimicag.2018.01.006","article-title":"Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016)","volume":"51","author":"Pfaller","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jhin.2019.09.001_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.diagmicrobio.2017.02.020","article-title":"Antimicrobial activity of tigecycline and cefoperazone\/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013\u20132014)","volume":"88","author":"Pfaller","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.001_bib30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/jac\/dki182","article-title":"Preservation of topoisomerase genetic sequences during in\u00a0vivo and in\u00a0vitro development of high-level resistance to ciprofloxacin in isogenic Stenotrophomonas maltophilia strains","volume":"56","author":"Valdezate","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2019.09.001_bib31","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/1462-2920.12408","article-title":"Interplay between intrinsic and acquired resistance to quinolones in Stenotrophomonas maltophilia","volume":"16","author":"Garcia-Leon","year":"2014","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.jhin.2019.09.001_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00301-18","article-title":"Overexpression of the efflux pumps SmeVWX and SmeDEF is a major cause of resistance to co-trimoxazole in Stenotrophomonas maltophilia","volume":"62","author":"Sanchez","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2019.09.001_bib33","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jmii.2016.12.007","article-title":"Risk factors for hospital acquisition of trimethoprim\u2013sulfamethoxazole resistant Stenotrophomonas maltophilia in adults: a matched case\u2013control study","volume":"50","author":"Wang","year":"2017","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.jhin.2019.09.001_bib34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.cmi.2018.11.008","article-title":"Fluoroquinolones versus trimethoprim\u2013sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis","volume":"25","author":"Ko","year":"2019","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670119303615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670119303615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:14:48Z","timestamp":1759292088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670119303615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0195670119303615"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2019.09.001","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2019.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}